본문 바로가기

Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
JOURNAL OF PHARMACY AND PHARMACOLOGY64(1) · pp.128 · 2012
피인용
Web of Science 7
JCR IF
JCR 2011 2.175
ISSN
0022-3573

저자

  1. Kong, Hyesik제1저자NCI, Urol Oncol Branch, US
  2. 이용현부산대학교, 약학대학, 약학부, 제약학전공, KO
  3. Kim, H부산대학교, 약학대학, 약학부, KO
  4. 홍성채부산대학교, 약학대학, 약학부, 제약학전공, KO
  5. Kim, Dae-Duk서울대학교, Pharmaceut Sci Res Inst, KO
  6. 윤정현부산대학교, 약학대학, 약학부, 약학전공, KO
  7. 정연진교신저자부산대학교, 약학대학, 약학부, 제약학전공, KO
  8. 김영미부산대학교, 약학대학, 약학부, 제약학전공, KO

초록

Objectives The systemic side effects of glucocorticoids have prevented their long-term use for treatment of inflammatory bowel disease. Colon-specific delivery of glucocorticoids has been adopted as a strategy to circumvent the toxicological trouble. Glucocorticoids delivered to the large intestine might undergo metabolisms by colonic microflora, which should affect therapeutic availability at the target site. It was investigated whether the susceptibility of glucocorticoids to the colonic metabolisms and pharmacologic intervention in the metabolism could modulate the therapeutic availability of colon-targeted glucocorticoids. Methods Various glucocorticoids and their derivatives, glucocorticoid 21-sulfate sodium compounds, were incubated in the cecal contents in the presence or absence of reduction inhibitors and the change in the levels of the drugs was monitored. Key findings The accumulation profiles of the corresponding glucocorticoids liberated from glucocorticoid 21-sulfate sodium compounds vary, depending on the metabolic susceptibility of glucocorticoids. Reduction inhibitors prevented the cecal metabolisms of glucocorticoids, which was most prominent for prednisolone (PD) and methylprednisolone (MP). Moreover, reduction inhibitors increased the accumulated amount of MP and PD released from PD- and MP-21-sulfate sodium in the cecal contents. Conclusions Our data provide information useful for selection of a glucocorticoid and a pharmacologic strategy for the design of an efficient colon-specific glucocorticoid prodrug.

키워드

colon-specific drug deliveryglucocorticoidinflammatory bowel diseasesulfated glucocorticoidINFLAMMATORY BOWEL-DISEASEPOTENTIAL PRODRUGSDRUG-DELIVERYRAT

식별자

WoS UID
000298011700015